HSA — authorised 24 September 1996
- Marketing authorisation holder: FRESENIUS KABI USA
- Status: likely_approved
🇸🇬 Naropin in Singapore
HSA authorised Naropin on 24 September 1996
Marketing authorisation
Naropin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Pain approved in Singapore
Frequently asked questions
Is Naropin approved in Singapore?
Yes. HSA authorised it on 24 September 1996.
Who is the marketing authorisation holder for Naropin in Singapore?
FRESENIUS KABI USA holds the Singaporean marketing authorisation.